Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL515408

MARIBAVIR
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
CC(C)Nc1nc2cc(Cl)c(Cl)cc2n1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O
ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID CHEMBL515408
Name MARIBAVIR
Phase Approved
Structure Type MOL
InChI Key KJFBVJALEQWJBS-XUXIUFHCSA-N
Therapeutic ✓ Yes

Known Names

1263-W-94 1263W94 BW-1263W94 GW-257406X Livtencity Maribavir
2
Targets
16
Activities
2
Assay Types
20
PK Parameters
20
Publications
6
Known Names
2
Indications
2
Mechanisms

Molecular Properties

376.2
MW (Da)
1.77
ALogP
7
HBA
4
HBD
99.8
PSA (Ų)
0.65
QED
0
Ro5 Violations
4
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 2021
Availability Prescription
Chirality Single Enantiomer

Routes of Administration

Oral

Flags

Natural Product First in Class
USAN Stem -vir
USAN Year 1998

Extended Properties

Molecular Formula C15H19Cl2N3O4
MW 376.24
Aromatic Rings 2
Heavy Atoms 24
NP-Likeness 0.14

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Serine/threonine-protein kinase BGLF4 inhibitor INHIBITOR Serine/threonine-protein kinase BGLF4 ✓ ✓
Phosphotransferase pUL97 inhibitor INHIBITOR Serine/threonine protein kinase UL97 ✓ ✓

Indications

Cytomegalovirus Infections Virus Diseases

ATC Classification

J05AX10
maribavir
Level 1: ANTIINFECTIVES FOR SYSTEMIC USE
Level 2: ANTIVIRALS FOR SYSTEMIC USE

Activity Summary

EC50 12 meas. best 7.08
IC50 4 meas. best 6.17

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Human betaherpesvirus 5
CHEMBL371
 EC50 7.08 6.6692 84.0 12
Histone deacetylase 6
CHEMBL1865
 IC50 6.17 6.17 669.0 1

Pharmacokinetic Data

Parameter Value Units Species
AUC 20500.0 ng.hr.mL-1 Homo sapiens
AUC 14700.0 ng.hr.mL-1 Homo sapiens
AUC 17400.0 ng.hr.mL-1 Homo sapiens
AUC 15600.0 ng.hr.mL-1 Homo sapiens
AUC 194000.0 ng.hr.mL-1 Homo sapiens
AUC 173000.0 ng.hr.mL-1 Homo sapiens
AUC 126000.0 ng.hr.mL-1 Homo sapiens
AUC 119000.0 ng.hr.mL-1 Homo sapiens
Cmax 2657.88 nM Homo sapiens
Cmax 4252.6 nM Homo sapiens
Cmax 57941.74 nM Homo sapiens
Cmax 52625.98 nM Homo sapiens
T1/2 11.8 hr Homo sapiens
T1/2 6.83 hr Homo sapiens
T1/2 6.88 hr Homo sapiens
T1/2 5.73 hr Homo sapiens
Tmax 5.5 hr Homo sapiens
Tmax 2.5 hr Homo sapiens
Tmax 1.9 hr Homo sapiens
Tmax 1.7 hr Homo sapiens

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Human betaherpesvirus 5 EC50 = 84.0 nM 7.08 Antiviral activity against Human cytomegalovirus T2899 expressing wild type UL27... 18981262
Human betaherpesvirus 5 EC50 = 95.0 nM 7.02 Antiviral activity against Human cytomegalovirus T2211 expressing wild type UL27... 18981262
Human betaherpesvirus 5 EC50 = 160.0 nM 6.8 Antiviral activity against Human cytomegalovirus T2981 expressing UL27 kinase wi... 18981262
Human betaherpesvirus 5 EC50 = 190.0 nM 6.72 Antiviral activity against Human cytomegalovirus T2867 expressing UL27 kinase wi... 18981262
Human betaherpesvirus 5 EC50 = 190.0 nM 6.72 Antiviral activity against Human cytomegalovirus T3020 expressing UL27 kinase wi... 18981262
Human betaherpesvirus 5 EC50 = 200.0 nM 6.7 Antiviral activity against Human cytomegalovirus T3053 expressing UL27 kinase wi... 18981262
Human betaherpesvirus 5 EC50 = 210.0 nM 6.68 Antiviral activity against Human cytomegalovirus T3037 expressing UL27 kinase wi... 18981262
Human betaherpesvirus 5 EC50 = 210.0 nM 6.68 Antiviral activity against Human cytomegalovirus T2898 expressing UL27 kinase wi... 18981262
Human betaherpesvirus 5 EC50 = 230.0 nM 6.64 Antiviral activity against Human cytomegalovirus T3019 expressing UL27 kinase wi... 18981262
Human betaherpesvirus 5 EC50 = 240.0 nM 6.62 Antiviral activity against Human cytomegalovirus T2767 expressing UL27 kinase wi... 18981262
Human betaherpesvirus 5 EC50 = 290.0 nM 6.54 Antiviral activity against Human cytomegalovirus T2931 expressing UL27 kinase 30... 18981262
Histone deacetylase 6 IC50 = 669.0 nM 6.17 Determination of IC50 values for inhibition of enzymatic assay of human HDAC6 wi... -
Human betaherpesvirus 5 EC50 = 1480.0 nM 5.83 Antiviral activity against Human cytomegalovirus T2890 expressing UL97 kinase wi... 18981262

Literature References

PubMed DOI Target Context # Activities
18316526 10.1128/aac.00951-07 Homo sapiens 41
18981262 10.1128/aac.01177-08 Human betaherpesvirus 5 32
- 10.6019/CHEMBL4808148 Histone deacetylase 6 4
28408228 10.1016/j.bmcl.2017.03.100 Human alphaherpesvirus 1 2
19112024 10.1016/j.bmc.2008.11.075 Human betaherpesvirus 6 2
- 10.6019/CHEMBL4651402 SARS-CoV-2 2
- 10.6019/CHEMBL4513161 Pseudomonas aeruginosa 2
- 10.6019/CHEMBL4495565 SARS-CoV-2 2
- 10.6019/CHEMBL4495564 Replicase polyprotein 1ab 1
- 10.6019/CHEMBL4513161 Candida albicans 1
- 10.6019/CHEMBL4513161 Cryptococcus neoformans 1
- 10.6019/CHEMBL4513161 Escherichia coli 1
- 10.6019/CHEMBL4513161 Klebsiella pneumoniae 1
- 10.21203/rs.3.rs-23951/v1 SARS-CoV-2 1
- 10.6019/CHEMBL4513161 Acinetobacter baumannii 1
- 10.6019/CHEMBL4513161 Staphylococcus aureus 1
- 10.6019/CHEMBL4513161 Erythrocyte 1
- 10.6019/CHEMBL4513161 HEK293 1
28408228 10.1016/j.bmcl.2017.03.100 Unchecked 1
28408228 10.1016/j.bmcl.2017.03.100 Vero C1008 1

Data from ChEMBL 36 via Core Engine